Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-01 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 3108 | $49.34 - $50.25 | $153,626 |
| 2024-10-01 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 8077 | $49.34 - $50.25 | $399,240 |
| 2024-10-01 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 3108 | $49.34 - $50.25 | $153,626 |
| 2024-10-01 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 21633 | $49.34 - $50.25 | $1,069,305 |
| 2024-08-28 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 10705 | $47.16 - $48.03 | $507,743 |
| 2024-08-28 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 13531 | $47.16 - $48.03 | $641,779 |
| 2024-08-28 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 10705 | $47.16 - $48.03 | $507,743 |
| 2024-08-28 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 115004 | $47.16 - $48.03 | $5,454,706 |
| 2024-08-27 | SOLENO THERAPEUTICS INC | Vivo Opportunity ...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 1025000 | $47.22 - $48.73 | $49,210,750 |
| 2024-08-15 | SOLENO THERAPEUTICS INC | Bir Dawn Carter
(Director) |
A | Common Stock | A | 13000 | $0.00 - $0.00 | $0 |
| 2024-08-05 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 10974 | $43.64 - $46.14 | $500,397 |
| 2024-08-05 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 14983 | $43.64 - $46.14 | $683,200 |
| 2024-08-05 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 11009 | $43.64 - $46.14 | $501,991 |
| 2024-08-05 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 127344 | $43.64 - $46.14 | $5,806,693 |
| 2024-07-17 | SOLENO THERAPEUTICS INC | Manning Meredith
(Chief Commercial Officer) |
A | Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-07-17 | SOLENO THERAPEUTICS INC | Huang Michael F.
(Sr. VP of Clinical Development) |
A | Common Stock | A | 35000 | $0.00 - $0.00 | $0 |
| 2024-07-17 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
A | Common Stock | A | 85000 | $0.00 - $0.00 | $0 |
| 2024-07-17 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
A | Common Stock | A | 85000 | $0.00 - $0.00 | $0 |
| 2024-07-17 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
A | Common Stock | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-07-01 | SOLENO THERAPEUTICS INC | Yen Kristen
(SEE REMARKS) |
S | Common Stock | D | 2170 | $41.22 - $41.63 | $90,135 |
| 2024-07-01 | SOLENO THERAPEUTICS INC | Mackaness James H
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 7190 | $41.22 - $41.63 | $298,652 |
| 2024-07-01 | SOLENO THERAPEUTICS INC | Hirano Patricia C
(SEE REMARKS) |
S | Common Stock | D | 2170 | $41.22 - $41.63 | $90,135 |
| 2024-07-01 | SOLENO THERAPEUTICS INC | Anish Bhatnagar
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 19256 | $41.22 - $41.63 | $799,843 |
| 2024-06-06 | SOLENO THERAPEUTICS INC | Volck Birgitte
(Director) |
A | Common Stock | A | 6500 | $0.00 - $0.00 | $0 |
| 2024-06-06 | SOLENO THERAPEUTICS INC | Sinclair Andrew
(Director) |
A | Common Stock | A | 6500 | $0.00 - $0.00 | $0 |
| 2024-06-06 | SOLENO THERAPEUTICS INC | Pauls Matthew
(Director) |
A | Common Stock | A | 6500 | $0.00 - $0.00 | $0 |
| 2024-06-06 | SOLENO THERAPEUTICS INC | MARIO ERNEST
(Director) |
A | Common Stock | A | 6500 | $0.00 - $0.00 | $0 |
| 2024-06-06 | SOLENO THERAPEUTICS INC | Harris William G
(Director) |
A | Common Stock | A | 6500 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |